Literature DB >> 16764687

Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells.

Cuixia Tian1, Grace K Kron, Kevin M Dischert, James N Higginbotham, James E Crowe.   

Abstract

Diminished neonatal antibody responses following infection or immunization may stem in part from intrinsic characteristics of neonatal B cells. In this study, we used B-cell subset sorting combined with gene expression assays to investigate major differences in the expression of host genes in neonatal and adult naïve B cells. We discovered significantly reduced expression of the interleukin (IL)-4 receptor alpha chain and reduced IL-4-induced signalling in neonatal B cells. Neonatal naïve B cells were susceptible to more rapid and more profound levels of apoptosis when cultured in vitro. They also exhibited a limited response to IL-4 treatment compared with adult cells. The expression level of the IL-13 receptor alpha 1 chain, a key component of the IL-13 receptor/IL-4 type II receptor, and the response to IL-13 treatment for protection against apoptosis in neonatal B cells were similar to those of the adult B cells. These studies suggest a possible mechanism underlying the limited magnitude and durability of neonatal antibody responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16764687      PMCID: PMC1782340          DOI: 10.1111/j.1365-2567.2006.02405.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4.

Authors:  V A Illera; C E Perandones; L L Stunz; D A Mower; R F Ashman
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

Review 2.  Structure of the IL4 receptor and signal transduction mechanism of IL4.

Authors:  K Izuhara; G Yang; A Miyajima; M Howard; N Harada
Journal:  Res Immunol       Date:  1993-10

3.  B cell growth-promoting activity of recombinant human interleukin 4.

Authors:  T Defrance; B Vanbervliet; J P Aubry; Y Takebe; N Arai; A Miyajima; T Yokota; F Lee; K Arai; J E de Vries
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

4.  IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells.

Authors:  H Renz; J Domenico; E W Gelfand
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

5.  Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of B cells to the anti-IgM signal.

Authors:  P D Hodgkin; N F Go; J E Cupp; M Howard
Journal:  Cell Immunol       Date:  1991-04-15       Impact factor: 4.868

6.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression.

Authors:  J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  A sequential study of human B lymphocyte function from birth to two years of age.

Authors:  U Andersson; G Bird; S Britton
Journal:  Acta Paediatr Scand       Date:  1981-11

8.  Histological distribution of the interleukin-4 receptor (IL4R) within the normal and pathological synovium.

Authors:  A Demazière; R Leek; N A Athanasou
Journal:  Rev Rhum Mal Osteoartic       Date:  1992-03

9.  Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.

Authors:  E A Clark; G L Shu; B Lüscher; K E Draves; J Banchereau; J A Ledbetter; M A Valentine
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

10.  Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1.

Authors:  E S Vitetta; J Ohara; C D Myers; J E Layton; P H Krammer; W E Paul
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  10 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Repository corticotrophin injection exerts direct acute effects on human B cell gene expression distinct from the actions of glucocorticoids.

Authors:  A L Benko; C A McAloose; P M Becker; D Wright; T Sunyer; Y I Kawasawa; N J Olsen; W J Kovacs
Journal:  Clin Exp Immunol       Date:  2018-01-12       Impact factor: 4.330

3.  Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates.

Authors:  Whitney A Young; Eleanor A Fallon; Daithi S Heffernan; Philip A Efron; William G Cioffi; Alfred Ayala
Journal:  Surgery       Date:  2016-12-21       Impact factor: 3.982

Review 4.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

Review 5.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

6.  The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations.

Authors:  John V Williams; Jörn-Hendrik Weitkamp; David L Blum; Bonnie J LaFleur; James E Crowe
Journal:  Mol Immunol       Date:  2009-10-04       Impact factor: 4.407

Review 7.  Immunity to RSV in Early-Life.

Authors:  Laura Lambert; Agnes M Sagfors; Peter J M Openshaw; Fiona J Culley
Journal:  Front Immunol       Date:  2014-09-29       Impact factor: 7.561

Review 8.  Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma.

Authors:  Katherine H Restori; Bharat T Srinivasa; Brian J Ward; Elizabeth D Fixman
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

9.  Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection.

Authors:  John S Tregoning; Belinda Lei Wang; Jacqueline U McDonald; Yuko Yamaguchi; James A Harker; Michelle Goritzka; Cecilia Johansson; Alexander Bukreyev; Peter L Collins; Peter J Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 10.  Strategies for active and passive pediatric RSV immunization.

Authors:  Katherine M Eichinger; Jessica L Kosanovich; Madeline Lipp; Kerry M Empey; Nikolai Petrovsky
Journal:  Ther Adv Vaccines Immunother       Date:  2021-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.